Keywords: Tumors (Post-Treatment), Brain, Glioma
Motivation: For glioma patients undergoing treatment, the current criteria for evaluating treatment response only use anatomical MRI images, providing insufficient information for challenging cases like pseudo-progression and pseudo-response.
Goal(s): Chemical Exchange Saturation Transfer (CEST) imaging of the tumor region can provide metabolic information for prognosis and treatment response evaluation.
Approach: High-resolution CEST acquisition at 7T is implemented in the multi-modal brain cancer trial for baseline and after-treatment scans.
Results: CEST scan of the glioma region provides crucial metabolic information that cannot be retrieved from anatomical images alone.
Impact: In combination with the clinical anatomical images, acquiring CEST data for glioma patients at 7T is beneficial for the monitoring of tumor progression and the evaluation of treatment response.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords